Cargando…
Intérêt de la TEP-TDM dans le cancer broncho-pulmonaire primitif non à petite cellule
Bronchopulmonary cancer is a real public health problem. Morphological imaging plays a central role in its diagnosis, staging as well as post-therapeutic assessment but it has some limitations. Metabolic imaging is a more recent technique which allows to significantly improve the overall imagery per...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The African Field Epidemiology Network
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5903710/ https://www.ncbi.nlm.nih.gov/pubmed/29675123 http://dx.doi.org/10.11604/pamj.2017.28.289.13130 |
_version_ | 1783314980491231232 |
---|---|
author | Soumia, Fdil Leila, Achachi Mohamed, Raoufi Laila, Herrak Mustapha, Elftouh |
author_facet | Soumia, Fdil Leila, Achachi Mohamed, Raoufi Laila, Herrak Mustapha, Elftouh |
author_sort | Soumia, Fdil |
collection | PubMed |
description | Bronchopulmonary cancer is a real public health problem. Morphological imaging plays a central role in its diagnosis, staging as well as post-therapeutic assessment but it has some limitations. Metabolic imaging is a more recent technique which allows to significantly improve the overall imagery performance. We conducted a retrospective, descriptive and analytical study at the Ibn Sina Hospital and at the Military Hospital of instruction Mohammed V in Rabat over a period of 18 months, between September 2014 and February 2016, in order to evaluate the role of Fluorodeoxyglucose-PET/CT in the staging and restaging of non-small cell bronchopulmonary cancer. Initial staging showed a vast majority of locally advanced and metastatic stages: stage IV (40%), Stage IIIB (36%), Stage IIIA (16%), Stage II (8%). PET-CT allowed to detect new sites which were not initially seen on CT scan in 24 cases: 15 new ganglion sites, 8 new adrenal sites and 6 sites of bone lesions. PET/CT allowed to modify initial tumor stage in 60% of cases: upstaging in 23 patients (46%) and downstaging in 7 patients(14%). The initial stage remained unchanged in 40% of patients. Our study confirms the data from the literature concerning the superiority of PET-CT in comparison with CT scan, but only in the optimization of the non-small cell bronchopulmonary cancer management, in particular in locoregional and distant staging. |
format | Online Article Text |
id | pubmed-5903710 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | The African Field Epidemiology Network |
record_format | MEDLINE/PubMed |
spelling | pubmed-59037102018-04-19 Intérêt de la TEP-TDM dans le cancer broncho-pulmonaire primitif non à petite cellule Soumia, Fdil Leila, Achachi Mohamed, Raoufi Laila, Herrak Mustapha, Elftouh Pan Afr Med J Case Series Bronchopulmonary cancer is a real public health problem. Morphological imaging plays a central role in its diagnosis, staging as well as post-therapeutic assessment but it has some limitations. Metabolic imaging is a more recent technique which allows to significantly improve the overall imagery performance. We conducted a retrospective, descriptive and analytical study at the Ibn Sina Hospital and at the Military Hospital of instruction Mohammed V in Rabat over a period of 18 months, between September 2014 and February 2016, in order to evaluate the role of Fluorodeoxyglucose-PET/CT in the staging and restaging of non-small cell bronchopulmonary cancer. Initial staging showed a vast majority of locally advanced and metastatic stages: stage IV (40%), Stage IIIB (36%), Stage IIIA (16%), Stage II (8%). PET-CT allowed to detect new sites which were not initially seen on CT scan in 24 cases: 15 new ganglion sites, 8 new adrenal sites and 6 sites of bone lesions. PET/CT allowed to modify initial tumor stage in 60% of cases: upstaging in 23 patients (46%) and downstaging in 7 patients(14%). The initial stage remained unchanged in 40% of patients. Our study confirms the data from the literature concerning the superiority of PET-CT in comparison with CT scan, but only in the optimization of the non-small cell bronchopulmonary cancer management, in particular in locoregional and distant staging. The African Field Epidemiology Network 2017-12-04 /pmc/articles/PMC5903710/ /pubmed/29675123 http://dx.doi.org/10.11604/pamj.2017.28.289.13130 Text en © Fdil Soumia et al. http://creativecommons.org/licenses/by/2.0/ The Pan African Medical Journal - ISSN 1937-8688. This is an Open Access article distributed under the terms of the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Series Soumia, Fdil Leila, Achachi Mohamed, Raoufi Laila, Herrak Mustapha, Elftouh Intérêt de la TEP-TDM dans le cancer broncho-pulmonaire primitif non à petite cellule |
title | Intérêt de la TEP-TDM dans le cancer broncho-pulmonaire primitif non à petite cellule |
title_full | Intérêt de la TEP-TDM dans le cancer broncho-pulmonaire primitif non à petite cellule |
title_fullStr | Intérêt de la TEP-TDM dans le cancer broncho-pulmonaire primitif non à petite cellule |
title_full_unstemmed | Intérêt de la TEP-TDM dans le cancer broncho-pulmonaire primitif non à petite cellule |
title_short | Intérêt de la TEP-TDM dans le cancer broncho-pulmonaire primitif non à petite cellule |
title_sort | intérêt de la tep-tdm dans le cancer broncho-pulmonaire primitif non à petite cellule |
topic | Case Series |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5903710/ https://www.ncbi.nlm.nih.gov/pubmed/29675123 http://dx.doi.org/10.11604/pamj.2017.28.289.13130 |
work_keys_str_mv | AT soumiafdil interetdelateptdmdanslecancerbronchopulmonaireprimitifnonapetitecellule AT leilaachachi interetdelateptdmdanslecancerbronchopulmonaireprimitifnonapetitecellule AT mohamedraoufi interetdelateptdmdanslecancerbronchopulmonaireprimitifnonapetitecellule AT lailaherrak interetdelateptdmdanslecancerbronchopulmonaireprimitifnonapetitecellule AT mustaphaelftouh interetdelateptdmdanslecancerbronchopulmonaireprimitifnonapetitecellule |